Peptides studied for immune modulation and inflammatory balance — thymic and anti-inflammatory peptides — with a neutral look at the evidence. Every claim is sourced on each peptide's guide.
Immune-support peptides are studied for modulating immune activity and inflammatory balance — steering T-cell function and tamping down excessive inflammation rather than simply "boosting" immunity. The thymic peptides, produced by the thymus, are central to T-cell development, which is why they dominate this research.
Most of this area is adjunct and investigational. Several peptides have approval in other countries for specific conditions but remain research compounds in the US context, so the framing here is about what's studied, not what's prescribed.
Thymic peptide studied for T-cell and immune modulation.
Pineal tetrapeptide studied for immune and telomere markers.
Anti-inflammatory tripeptide studied for inflammatory pathways.
Thymosin Alpha-1 is the most-studied immune peptide and is approved in numerous countries as an adjunct for certain infections and cancers, though it isn't FDA-approved for general immune use in the US. Epitalon is researched for pineal and immune-aging markers but rests mostly on older, smaller studies.
KPV reappears here as an anti-inflammatory peptide that acts on inflammatory pathways rather than on immune-cell development specifically — a recurring theme across these pillars.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.